Clinical Research Directory
Browse clinical research sites, groups, and studies.
Analgesic Requirement for Post-Operative Pain Control in TLIP Interbody Fusion
Sponsor: Foundation for Orthopaedic Research and Education
Summary
The goal of this clinical trail is to to compare the efficacy of thoracolumbar interfascial plane block with Exparel vs with standard of care 0.25% Bupivacaine HCl in patients undergoing 1-3 level elective transforaminal lumbar interbody fusion. The investigators hypothesize that thoracolumbar interfascial plane block with Exparel will outperform standard of care (supplemented with interfascial plane block of 0.25% Bupivacaine HCl) with regards to pain reduction, narcotic use, length of hospital stay, time to mobilization with physical therapy, narcotic usage in the hospital, and post operative pain scores.
Official title: Analgesic Requirement for Post-Operative Pain Control in Elective 1-3 Level Transforaminal Lumbar Interbody Fusion: Comparison of Thoracolumbar Interfascial Plane Block With Exparel to Bupivacaine HCl
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
76
Start Date
2024-04-30
Completion Date
2026-03-01
Last Updated
2025-02-25
Healthy Volunteers
No
Interventions
Exparel
20 mL of EXPAREL 266mg mixed with 10 mL of 0.25% bupivacaine
Bupivacain
Standard of care will consist of 0.25% Bupivacaine HCl TLIP injection 30mL
Locations (1)
Foundation for Orthopaedic Research and Education
Tampa, Florida, United States